|
| 37532622 | Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial. | Parkinsonism Relat Disord | 2023 |
| 36343661 | Mitochondrial haplogroups and cognitive progression in Parkinson's disease. | Brain | 2023 |
| 37730914 | Microglia-dependent neuroprotective effects of 4-octyl itaconate against rotenone-and MPP+-induced neurotoxicity in Parkinson's disease. | | 2023 |
| 37793724 | Probable Parasomnias and Mortality: A Prospective Study in US Men. | | 2023 |
| 37700241 | The STEPWISE study: study protocol for a smartphone-based exercise solution for people with Parkinson's Disease (randomized controlled trial). | BMC Neurol | 2023 |
| 36840949 | Randomized trial of inosine for urate elevation in amyotrophic lateral sclerosis. | Muscle Nerve | 2023 |
| 37344230 | Association of Polyunsaturated Fatty Acids and Clinical Progression in Patients With ALS: Post Hoc Analysis of the EMPOWER Trial. | | 2023 |
| 37398302 | Peripheral MC1R activation modulates immune responses and is neuroprotective in a mouse model of Parkinson's disease. | | 2023 |
| 37315105 | Subjective Cognitive Decline in Women with Features Suggestive of Prodromal Parkinson's Disease. | | 2023 |
| 37314861 | Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes. | Ann Neurol | 2023 |
| 36942368 | LRRK2-Targeting Therapies March Through the Valley of Death. | | 2023 |
| 36938854 | Long-Term Intake of Folate, Vitamin B6, and Vitamin B12 and the Incidence of Parkinson's Disease in a Sample of U.S. Women and Men. | | 2023 |
| 36865634 | Enrollment of Participants From Marginalized Racial and Ethnic Groups: A Comparative Assessment of the STEADY-PD III and SURE-PD3 Trials. | | 2023 |
| 37302021 | Providing genetic testing and genetic counseling for Parkinson's disease to the community. | | 2023 |
| 35082171 | Intake of Flavonoids and Flavonoid-Rich Foods and Mortality Risk Among Individuals With Parkinson Disease: A Prospective Cohort Study. | Neurology | 2022 |
| 35970592 | What to Test in Parkinson Disease Prevention Trials? Repurposed, Low-Risk, and Gene-Targeted Drugs. | Neurology | 2022 |
| 35970591 | Who to Enroll in Parkinson Disease Prevention Trials? The Case for Composite Prodromal Cohorts. | Neurology | 2022 |
| 35970586 | Path to Parkinson Disease Prevention: Conclusion and Outlook. | Neurology | 2022 |
| 35841312 | Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory Modeling. | Movement Disorders | 2022 |
| 36219787 | Planning for Prevention of Parkinson Disease: Now Is the Time. | Neurology | 2022 |
| 35984656 | Association of Diet and Physical Activity With All-Cause Mortality Among Adults With Parkinson Disease. | JAMA network open | 2022 |
| 35466957 | Inhibition of Neuroinflammation May Mediate the Disease-Modifying Effects of Exercise: Implications for Parkinson's Disease. | Journal of Parkinson's Disease | 2022 |
| 34982121 | Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease-Reply. | JAMA - Journal of the American Medical Association | 2022 |
| 35202842 | Designing the Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease study. | Contemporary Clinical Trials | 2022 |
| 35224425 | A Smartphone Application as an Exploratory Endpoint in a Phase 3 Parkinson's Disease Clinical Trial: A Pilot Study. | Digit Biomark | 2022 |
| 34380747 | Prediagnostic Neurofilament Light Chain Levels in Amyotrophic Lateral Sclerosis. | Neurology | 2021 |
| 33958783 | Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease. | Nat Genet | 2021 |
| 33847749 | Association of Sleepwalking and REM Sleep Behavior Disorder With Parkinson Disease in Men. | JAMA network open | 2021 |
| 33892050 | Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease. | Neurobiology of Disease | 2021 |
| 33942376 | Expectations of Benefit in a Trial of a Candidate Disease-Modifying Treatment for Parkinson Disease. | Movement Disorders | 2021 |
| 33935102 | Non-Motor Features of Parkinson's Disease in Women. | Journal of Parkinson's Disease | 2021 |
| 34250483 | Cognitive function in men with non-motor features of Parkinson's disease. | BMJ Neurology Open | 2021 |
| 33649343 | The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism. | NPJ Parkinsons Dis | 2021 |
| 33315105 | Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial. | JAMA Neurol | 2021 |
| 32985910 | Pre-diagnostic plasma lipid levels and the risk of amyotrophic lateral sclerosis. | Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | 2021 |
| 33350601 | Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD). | Ann Clin Transl Neurol | 2021 |
| 34561166 | Seeking progress in disease modification in Parkinson disease. | Parkinsonism Relat Disord | 2021 |
| 32773396 | Does Serum Urate Change as Parkinson's Disease Progresses? | Journal of Parkinson's Disease | 2020 |
| 32250320 | Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson's Disease in the Harvard Biomarkers Study. | J Parkinsons Dis | 2020 |
| 32250318 | Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson's Disease. | J Parkinsons Dis | 2020 |
| 31680121 | Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists. | Genetics in Medicine | 2020 |
| 31948788 | Big health data and Parkinson's disease epidemiology: Challenges and opportunities. | Parkinsonism and Related Disorders | 2020 |
| 32399169 | Long-Term Use of Antibiotics and Risk of Parkinson's Disease in the Nurses' Health Study. | Parkinson's Disease | 2020 |
| 31772350 | Correction: Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists. | Genetics in Medicine | 2020 |
| 32102975 | Disease modification and biomarker development in Parkinson disease: Revision or reconstruction? | Neurology | 2020 |
| 33205384 | Approaches to Disease Modification for Parkinson's Disease: Clinical Trials and Lessons Learned. | | 2020 |
| 32540937 | β-Glucocerebrosidase activity in <i>GBA</i>-linked Parkinson disease: The type of mutation matters. | Neurology | 2020 |
| 32925106 | Barriers and Motivators to Engage in Exercise for Persons with Parkinson's Disease. | Journal of Parkinson's Disease | 2020 |
| 32817391 | Diet pattern and prodromal features of Parkinson disease. | Neurology | 2020 |
| 32636740 | Chasing Protection in Parkinson's Disease: Does Exercise Reduce Risk and Progression? | Frontiers in Aging Neuroscience | 2020 |